Chemoinformaics analysis of 6,7-Bisepoxy-sec-calamenene
| Molecular Weight | 232.323 | nRot | 1 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
| Exact Molecular Weight | 232.146 | nRing | 3 |
| Solubility: LogS | -4.375 | nHRing | 2 |
| Solubility: LogP | 4.046 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 39.9899 |
| nHD | 0 | BPOL | 23.5361 |
| QED | 0.734 |
| Synth | 4.757 |
| Natural Product Likeliness | 1.23 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.558 |
| Pgp-sub | 0.007 |
| HIA | 0.006 |
| CACO-2 | -4.681 |
| MDCK | 0.0000206 |
| BBB | 0.168 |
| PPB | 0.942165 |
| VDSS | 1.859 |
| FU | 0.0428442 |
| CYP1A2-inh | 0.109 |
| CYP1A2-sub | 0.777 |
| CYP2c19-inh | 0.588 |
| CYP2c19-sub | 0.961 |
| CYP2c9-inh | 0.184 |
| CYP2c9-sub | 0.405 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.903 |
| CYP3a4-inh | 0.499 |
| CYP3a4-sub | 0.806 |
| CL | 16.331 |
| T12 | 0.245 |
| hERG | 0.025 |
| Ames | 0.364 |
| ROA | 0.08 |
| SkinSen | 0.205 |
| Carcinogencity | 0.744 |
| EI | 0.258 |
| Respiratory | 0.081 |
| NR-Aromatase | 0.286 |
| Antiviral | Yes |
| Prediction | 0.727331 |